Alternatives to Pharmasolution

Global life sciences company providing diagnostic and biopharma laboratory services.

Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.

Cloud-based platform for clinical trial data management and analytics.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI-powered medical imaging analysis and diagnostic support for radiologists.

Data-driven software solutions for precision medicine and pharmaceutical development.

AI-powered breast cancer detection and risk assessment solutions.

Primary research platform connecting healthcare and life sciences knowledge seekers with subject matter experts.

Specialized services for pharmaceutical and life sciences clients across product development and commercialization.

Pioneered prescription digital therapeutics for serious diseases, integrating software with pharmaceuticals.

Develops a computational model of the human body for drug discovery and development.

AI-powered digital platform for life sciences, accelerating clinical research and drug development.

A global oncology company developing and commercializing innovative cancer treatments.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Automating pharmaceutical compounding for personalized medicine.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

A global leader in clinical pharmacology and bioanalytical sciences.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

Verana Health is a data science company focused on real-world evidence for ophthalmology.

Genomic data analysis platform for rare diseases and cancer.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

A biotechnology company developing genetic therapies for rare disorders.

Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

A biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension.

H1 is a healthcare data platform that connects life sciences companies with healthcare professionals.

Developing oral small molecule medicines for immunological and chronic diseases.

Pioneering vision restoration therapies for severe retinal degenerations.

Advancing deupirfenidone as a potential new standard of care for Idiopathic Pulmonary Fibrosis (IPF).

Digital pathology imaging technology and AI-driven precision pathology software.

A biopharmaceutical company focused on developing and commercializing therapies for rare diseases.

Developing a new class of anti-IgE therapy for multiple atopic conditions.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

Advancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.

Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.

A biotechnology company focused on developing novel enzyme-based therapies for reflux disease.

Provides regulated, secure, and high-yield digital asset solutions for institutional and corporate treasuries.

Global immunology company developing antibody-based therapies for severe autoimmune diseases.

Immunotherapy company targeting oncology and autoimmune diseases.

Developing first-in-class oral therapy for BK polyomavirus infections.

NantHealth provides a suite of healthcare solutions focused on precision medicine and data analytics.

Developing novel male contraceptives.

Advancing scalable microbiome-based therapeutics for severe and chronic diseases.

Clinical-stage immunotherapy company developing novel treatments for cancer.

A biopharmaceutical company developing RNA interference (RNAi)-based medicines.

Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.

Clinical-stage biopharmaceutical company developing transformative, best-in-class neuropsychiatric therapies.

A biopharmaceutical company focused on drug discovery and development.

Advancing targeted alpha therapies.

Enabling pharmaceutical companies to deliver medications directly to patients at scale.

Wearable devices and AI for continuous health monitoring and early disease detection.

A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.